SB

Sylvie Beaubien

TP Tranzyme Pharma: 7 patents #6 of 19Top 35%
OT Ocera Therapeutics: 2 patents #14 of 37Top 40%
Overall (All Time): #568,685 of 4,157,543Top 15%
9
Patents All Time

Issued Patents All Time

Patent #TitleCo-InventorsDate
10040751 Intermediates for macrocyclic compounds Eric Marsault, Kamel Benakli, Hamid R. Hoveyda, Mark L. Peterson, Luc Ouellet +2 more 2018-08-07
9181298 Intermediates for macrocyclic compounds Eric Marsault, Kamel Benakli, Hamid R. Hoveyda, Mark L. Peterson, Luc Oullet +2 more 2015-11-10
8557765 Spatially-defined macrocycles incorporating peptide bond surrogates Pierre Deslongchamps, Yves Dory, Luc Ouellet, Gerald Villeneuve, Mahesh Ramaseshan +5 more 2013-10-15
8497242 Processes for intermediates for macrocyclic compounds Eric Marsault, Kamel Benakli, Hamid R. Hoveyda, Mark L. Peterson, Luc Ouellet +2 more 2013-07-30
8440851 Spatially-defined macrocyclic compounds useful for drug discovery Eric Marsault, Kamel Benakli, Hamid R. Hoveyda, Mark L. Peterson, Luc Ouellet +2 more 2013-05-14
8022252 Spatially-defined macrocyclic compounds useful for drug discovery Pierre Deslongchamps, Yves Dory, Kamel Benakli, Eric Marsault, Luc Ouellet +8 more 2011-09-20
7550431 Spatially-defined macrocycles incorporating peptide bond surrogates Pierre Deslongchamps, Yves Dory, Luc Ouellet, Gerald Villeneuve, Mahesh Ramaseshan +5 more 2009-06-23
7521420 Macrocyclic antagonists of the motilin receptor Graeme L. Fraser, Eric Marsault, Mark L. Peterson, Hamid R. Hoveyda, Kamel Benakli +1 more 2009-04-21
7452862 Conformationally-controlled biologically active macrocyclic small molecules as motilin antagonists or ghrelin agonists Pierre Deslongchamps, Yves Dory, Mark L. Peterson, Kamel Benakli, Eric Marsault +9 more 2008-11-18